100 related articles for article (PubMed ID: 16417523)
21. Positional dependence of non-native polar mutations on folding of CFTR helical hairpins.
Wehbi H; Gasmi-Seabrook G; Choi MY; Deber CM
Biochim Biophys Acta; 2008 Jan; 1778(1):79-87. PubMed ID: 17949679
[TBL] [Abstract][Full Text] [Related]
22. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
[TBL] [Abstract][Full Text] [Related]
23. Topogenesis of cystic fibrosis transmembrane conductance regulator (CFTR): regulation by the amino terminal transmembrane sequences.
Chen M; Zhang JT
Biochemistry; 1999 Apr; 38(17):5471-7. PubMed ID: 10220334
[TBL] [Abstract][Full Text] [Related]
24. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.
Farinha CM; Nogueira P; Mendes F; Penque D; Amaral MD
Biochem J; 2002 Sep; 366(Pt 3):797-806. PubMed ID: 12069690
[TBL] [Abstract][Full Text] [Related]
25. CFTR folding and maturation in cells.
Benharouga M; Sharma M; Lukacs GL
Methods Mol Med; 2002; 70():229-43. PubMed ID: 11917526
[No Abstract] [Full Text] [Related]
26. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
27. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
Du K; Sharma M; Lukacs GL
Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
[TBL] [Abstract][Full Text] [Related]
28. Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR.
Loo TW; Clarke DM
Biochem Pharmacol; 2017 Jul; 136():24-31. PubMed ID: 28366727
[TBL] [Abstract][Full Text] [Related]
29. Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking.
Gentzsch M; Choudhury A; Chang XB; Pagano RE; Riordan JR
J Cell Sci; 2007 Feb; 120(Pt 3):447-55. PubMed ID: 17213331
[TBL] [Abstract][Full Text] [Related]
30. Macromolecular interactions and ion transport in cystic fibrosis.
Guggino WB; Banks-Schlegel SP
Am J Respir Crit Care Med; 2004 Oct; 170(7):815-20. PubMed ID: 15447951
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
[TBL] [Abstract][Full Text] [Related]
32. Domain interdependence in the biosynthetic assembly of CFTR.
Cui L; Aleksandrov L; Chang XB; Hou YX; He L; Hegedus T; Gentzsch M; Aleksandrov A; Balch WE; Riordan JR
J Mol Biol; 2007 Jan; 365(4):981-94. PubMed ID: 17113596
[TBL] [Abstract][Full Text] [Related]
33. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
Scott-Ward TS; Amaral MD
FEBS J; 2009 Dec; 276(23):7097-109. PubMed ID: 19878303
[TBL] [Abstract][Full Text] [Related]
34. Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 2015 Dec; 290(49):29389-401. PubMed ID: 26507655
[TBL] [Abstract][Full Text] [Related]
35. Insertion of an arginine residue into the transmembrane segments corrects protein misfolding.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2006 Oct; 281(40):29436-40. PubMed ID: 16926162
[TBL] [Abstract][Full Text] [Related]
36. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
Ren HY; Grove DE; De La Rosa O; Houck SA; Sopha P; Van Goor F; Hoffman BJ; Cyr DM
Mol Biol Cell; 2013 Oct; 24(19):3016-24. PubMed ID: 23924900
[TBL] [Abstract][Full Text] [Related]
37. Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle.
Jih KY; Hwang TC
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4404-9. PubMed ID: 23440202
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic features of cystic fibrosis in Japan.
Kozawa Y; Yamamoto A; Nakakuki M; Fujiki K; Kondo S; Okada T; Fukuyasu T; Yamaguchi M; Taniguchi I; Nomura N; Liu L; Higuchi M; Niwa E; Sohma Y; Naruse S; Takeyama Y; Ishiguro H
J Hum Genet; 2023 Oct; 68(10):671-680. PubMed ID: 37217688
[TBL] [Abstract][Full Text] [Related]
39. Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases.
Ulloa-Aguirre A; Zariñán T; Gutiérrez-Sagal R; Tao YX
Front Endocrinol (Lausanne); 2022; 13():934685. PubMed ID: 36093106
[TBL] [Abstract][Full Text] [Related]
40. Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.
Han ST; Rab A; Pellicore MJ; Davis EF; McCague AF; Evans TA; Joynt AT; Lu Z; Cai Z; Raraigh KS; Hong JS; Sheppard DN; Sorscher EJ; Cutting GR
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
